Vaccine coverage, antibodies against measles, mumps, rubella, hepatitis B in inflammatory bowel disease and juvenile idiopathic arthritis children

Table 1 Demographic characteristics of patients with inflammatory bowel disease and juvenile idiopathic arthritis included in the study, n (%)/median (25^th-75^th percentiles)

Parameter	IBD (n = 97)	JIA (n = 170)	P value
Sex (females)	45 (46.4)	115 (67.7)	< 0.001
Age of the inclusion in the study	14.0 (11.0-16.2)	11.4 (7.6-14.8)	0.03
Age of the disease onset	11.0 (6.0-14.0)	6.0 (3.7-9.0)	0.01
Biological immunosuppressive treatment at study inclusion	88 (51.8)	32 (33.0)	< 0.0001
Immunosuppressive therapy at the time of the study	81 (83.5)	154 (90.6)	0.09

IBD: Inflammatory bowel disease; JIA: Juvenile idiopathic arthritis.